Dienogest reduces HSD17β1 expression and activity in endometriosis

Journal of Endocrinology

Volumn 225, Issue 2, 2015, Pages 69-76

  Mori, Taisuke ^a   Ito, Fumitake ^a   Matsushima, Hiroshi ^a   Takaoka, Osamu ^a   Koshiba, Akemi ^a   Tanaka, Yukiko ^a   Kusuki, Izumi ^a   Kitawaki, Jo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

17 hydroxysteroid dehydrogenase 1; Dienogest; Endometriosis; Ovarian endometrioma; Spheroid culture

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE 1; 17BETA HYDROXYSTEROID DEHYDROGENASE 12; 17BETA HYDROXYSTEROID DEHYDROGENASE 2; 17BETA HYDROXYSTEROID DEHYDROGENASE 7; AROMATASE; DIENOGEST; ESTROGEN SULFOTRANSFERASE; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; PROGESTERONE; STERYL SULFATASE; UNCLASSIFIED DRUG; ESTRADIOL 17BETA DEHYDROGENASE; HSD17B1 PROTEIN, HUMAN; NANDROLONE;

ADULT; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME ASSAY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; YOUNG ADULT;

ADULT; AROMATASE; CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL DEHYDROGENASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NANDROLONE; YOUNG ADULT;

EID: 84930789861     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-15-0052     Document Type: Article

References (34)

1. Beranic N & Rizner TL 2012 Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line. Journal of Steroid Biochemistry and Molecular Biology 132 303-310. (doi:10.1016/j.jsbmb.2012.07.004)
2. Bulun SE 2009 Endometriosis. New England Journal of Medicine 360 268-279. (doi:10.1056/NEJMra0804690)
3. Colette S, Defrère S, Van Kerk O, Van Langendonckt A, Dolmans MM & Donnez J 2013 Differential expression of steroidogenic enzymes according to endometriosis type. Fertility and Sterility 100 1642-1649. (doi:10.1016/j.fertnstert.2013.08.003)
4. Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, Husen B, Dunselman G & Groothuis P 2007 Estrogen metabolizing enzymes in endometrium and endometriosis. Human Reproduction 22 3148-3158. (doi:10.1093/humrep/dem310)
5. Day JM, Tutill HJ, Purohit A & Reed MJ 2008 Design and validation of specific inhibitors of 17β-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis. Endocrine-Related Cancer 15 665-692. (doi:10.1677/ERC-08-0042)
6. Delvoux B, D'Hooghe T, Kyama C, Koskimies P, Hermans RJ, Dunselman GA & Romano A 2014 Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions. Journal of Clinical Endocrinology andMetabolism 99 276-284. (doi:10.1210/jc.2013-2851)
7. Enzerink A, Salmenpera P, Kankuri E & Vaheri A 2009 Clustering of fibroblasts induces proinflammatory chemokine secretion promoting leukocyte migration. Molecular Immunology 46 1787-1795. (doi:10.1016/j.molimm.2009.01.018)
8. Fu L, Osuga Y, Morimoto C, Hirata T, Hirota Y, Yano T & Taketani Y 2008 Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fertility and Sterility 89 1344-1347. (doi:10.1016/j.fertnstert.2007.03.042)
9. Giudice LC 2010 Clinical practice. Endometriosis. New England Journal of Medicine 362 2389-2398. (doi:10.1056/NEJMcp1000274)
10. Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H & Terakawa N 2009 Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis - a randomized, double-blind, multicenter, controlled trial. Fertility and Sterility 91 675-681. (doi:10.1016/j.fertnstert.2007.12.080)
11. Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T & Terakawa N 2005 Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells. Fertility and Sterility 83 1530-1535. (doi:10.1016/j.fertnstert.2004.11.042)
12. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y & Honjo H 1997 Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biology of Reproduction 57 514-519. (doi:10.1095/biolreprod57.3.514)
13. Kitawaki J, Koshiba H, Ishihara H, Kusuki I, Tsukamoto K & Honjo H 2000 Progesterone induction of 17β-hydroxysteroid dehydrogenase type 2 during the secretory phase occurs in the endometrium of estrogendependent benign diseases but not in normal endometrium. Journal of Clinical Endocrinology and Metabolism 85 3292-3296. (doi:10.1210/jcem.85.9.6829)
14. Maeda N, Izumiya C, Taniguchi K, Matsushima S, Mita S, Shimizu Y & Fukaya T 2014 Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 177 48-51. (doi:10.1016/j.ejogrb.2014.03.019)
15. Matsuzaki S, Canis M, Pouly JL, Déchelotte PJ & Mage G 2006 Analysis of aromatase and 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Fertility and Sterility 85 308-313. (doi:10.1016/j.fertnstert.2005.08.017)
16. McCormack PL 2010 Dienogest: a review of its use in the treatment of endometriosis. Drugs 70 2073-2088. (doi:10.2165/11206320-000000000-00000)
17. Meriggiola MC, Bremner WJ, Costantino A, Bertaccini A, Morselli-Labate AM, Huebler D, Kaufmann G, Oettel M & Flamigni C 2002 Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men. Journal of Clinical Endocrinology and Metabolism 87 2107-2113. (doi:10.1210/jcem.87.5.8514)
18. Mita S, Shimizu Y, Notsu T, Imada K & Kyo S 2011 Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells. Fertility and Sterility 96 1485-1489. (doi:10.1016/j.fertnstert.2011.09.040)
19. Mita S, Shimizu Y, Sato A, Notsu T, Imada K & Kyo S 2014 Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β. Fertility and Sterility 101 595-601. (doi:10.1016/j.fertnstert.2013.10.038)
20. Moeller GM & Adamski J 2006 Multifunctionality of human 17β-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology 248 47-55. (doi:10.1016/j.mce.2005.11.031)
21. Momoeda M, Harada T, Terakawa N, Aso T, Fukunaga M, Hagino H & Taketani Y 2009 Long-term use of dienogest for the treatment of endometriosis. Journal of Obstetrics and Gynaecology Research 35 1069-1076. (doi:10.1111/j.1447-0756.2009.01076.x)
22. Noble LS, Simpson ER, Johns A & Bulun SE 1996 Aromatase expression in endometriosis. Journal of Clinical Endocrinology and Metabolism 81 174-179. (doi:10.1210/jcem.81.1.8550748)
23. Okada H, Nakajima T, Yoshimura T, Yasuda K & Kanzaki H 2001 The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Molecular Human Reproduction 7 341-347. (doi:10.1093/molehr/7.4.341)
24. Petraglia F, Hornung D, Seitz C, Faustmann T, Gerlinger C, Luisi S, Lazzeri L & Strowizki T 2012 Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Archives of Gynecology and Obstetrics 285 167-173. (doi:10.1007/s00404-011-1941-7)
25. Poirier D 2011 Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases. Journal of Steroid Biochemistry and Molecular Biology 125 83-94. (doi:10.1016/j.jsbmb.2010.12.007)
26. Sasagawa S, Shimizu Y, Kami H, Takeuchi T, Mita S, Imada K, Kato S & Mizuguchi K 2008 Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 73 222-231. (doi:10.1016/j.steroids.2007.10.003)
27. Shimizu Y, Takeuchi T, Mita S, Mizuguchi K, Kiyono T, Inoue M & Kyo S 2009 Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression. Molecular Human Reproduction 15 693-701. (doi:10.1093/molehr/gap042)
28. Shimizu Y, Mita S, Takeuchi T, Notsu T, Mizuguchi K & Kyo S 2011 Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system. Steroids 76 60-67. (doi:10.1016/j.steroids.2010.08.010)
29. Smuc T, Pucelj MR, Sinkovec J, Husen B, Thole H & Lanisnik Rizner T 2007 Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecological Endocrinology 23 105-111. (doi:10.1080/09513590601152219)
30. Strowitzki T, Marr J, Gerlinger C, Faustmann T & Seitz C 2010 Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human Reproduction 25 633-641. (doi:10.1093/humrep/dep469)
31. Utsunomiya H, Ito K, Suzuki T, Kitamura T, Kaneko C, Nakata T, Kiikura H, Okamura K, Yaegashi N & Sasano H 2004 Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clinical Cancer Research 10 5850-5856. (doi:10.1158/1078-0432. CCR-04-0040)
32. Vaheri A, Enzerink A, Rasanen K & Salmenpera P 2009 Nemosis, a novel way of fibroblast activation, in inflammation and cancer. Experimental Cell Research 315 1633-1638. (doi:10.1016/j.yexcr.2009.03.005)
33. Yamanaka K, Xu B, Suganuma I, Kusuki I, Mita S, Shimizu Y, Mizuguchi K & Kitawaki J 2012 Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture. Fertility and Sterility 97 477-482. (doi:10.1016/j.fertnstert.2011.11.005)
34. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Carr B & Bulun SE 1998 Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. Journal of Clinical Endocrinology and Metabolism 83 4474-4480. (doi:10.1210/jcem.83.12.5301)